Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone and Vitamin E in T2DM and NASH
NCT01002547Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jun 2010
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in Nonalcoholic steatohepatitis (NASH), sponsored by VA Office of Research & Development. Started Jun 2010; status: completed.
02
Drugs
pioglitazone
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01002547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002547.